Publications by authors named "Marianne Berdugo-Polak"

Macular edema is an increase in volume of the central area of the retina, responsible for visual acuity. Visual symptoms handicap the lives of millions of patients with macular edema secondary to chronic and sometimes acute retinal disease. Proteins that neutralize the vascular endothelial growth factor (VEGF) pathway or glucocorticoids, at the cost of repeated intraocular injections over years, limit visual symptoms.

View Article and Find Full Text PDF

Purpose: To evaluate the antimitotic and toxic effects of 5-chlorouracil (5-CU) and 5-fluorouracil (5-FU) and study their potential to delay filtering bleb closure in the rabbit eye when released by poly(ortho esters) (POE).

Methods: Rabbit Tenon fibroblasts and human conjunctival cells were incubated with various 5-CU and 5-FU concentrations. Antiproliferative effects and toxicity were evaluated at 24 and 72 hours by monotetrazolium, neutral red, and Hoechst tests and cell counting.

View Article and Find Full Text PDF

Synopsis of recent research by authors named "Marianne Berdugo-Polak"

  • - Marianne Berdugo-Polak's research primarily focuses on ocular health, particularly concerning conditions like macular edema and the evaluation of drug delivery systems in glaucoma treatment.
  • - In her 2020 article, she explores the mechanisms behind macular edema and emphasizes the limitations of current treatments using anti-VEGF proteins and glucocorticoids, which require repeated intraocular injections.
  • - Her earlier work in 2008 investigates the controlled delivery of 5-chlorouracil (5-CU) through poly(ortho esters) in filtering surgeries for glaucoma, assessing its efficacy and toxicity, with the goal of improving surgical outcomes.